(Q34222745)

31 July 2017

1 reference

title

Helicobacter pylori vaccines: lessons from small animal models (English)

1 reference

Helicobacter pylori infectious disease

31 July 2017

0 references

1 reference

Nedrud JG

1

1 reference

31 July 2017

language of work or name

1 reference

1 May 2001

1 reference

Scandinavian Journal of Immunology

31 July 2017

published in

1 reference

31 July 2017

volume

53

1 reference

31 July 2017

issue

5

1 reference

31 July 2017

page(s)

429-436

1 reference

Tyrosine-phosphorylated bacterial proteins: Trojan horses for the host cell

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2001.00912.X

Oral immunization with recombinant Helicobacter pylori urease induces secretory IgA antibodies and protects mice from challenge with Helicobacter felis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2001.00912.X

Novel intranasal immunization techniques for antibody induction and protection of mice against gastric Helicobacter felis infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2001.00912.X

Cholera toxin and cholera B subunit as oral-mucosal adjuvant and antigen vector systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2001.00912.X

Structure and mucosal adjuvanticity of cholera and Escherichia coli heat-labile enterotoxins

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2001.00912.X

Recombinant cholera toxin B subunit is not an effective mucosal adjuvant for oral immunization of mice against Helicobacter felis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2001.00912.X

Parenteral adjuvant activities of Escherichia coli heat-labile toxin and its B subunit for immunization of mice against gastric Helicobacter pylori infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2001.00912.X

Protection against Helicobacter pylori infection in mice by intragastric vaccination with H. pylori antigens is achieved using a non-toxic mutant of E. coli heat-labile enterotoxin (LT) as adjuvant.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2001.00912.X

Recombinant antigen-enterotoxin A2/B chimeric mucosal immunogens differentially enhance antibody responses and B7-dependent costimulation of CD4(+) T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2001.00912.X

Induction of mucosal and systemic immune response by oral immunization with H. pylori lysates encapsulated in poly(D,L-lactide-co-glycolide) microparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2001.00912.X

Protection of mice against gastric colonization by Helicobacter pylori by single oral dose immunization with attenuated Salmonella typhimurium producing urease subunits A and B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2001.00912.X

Safety and immunogenicity of phoP/phoQ-deleted Salmonella typhi expressing Helicobacter pylori urease in adult volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2001.00912.X

Pilot study of phoP/phoQ-deleted Salmonella enterica serovar typhimurium expressing Helicobacter pylori urease in adult volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2001.00912.X

Systemic immunization with urease protects mice against Helicobacter pylori infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2001.00912.X

Immunization of mice with urease vaccine affords protection against Helicobacter pylori infection in the absence of antibodies and is mediated by MHC class II-restricted responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2001.00912.X

Immunization of rhesus monkeys with a mucosal prime, parenteral boost strategy protects against infection with Helicobacter pylori

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2001.00912.X

Immune response against a cross-reactive epitope on the heat shock protein 60 homologue of Helicobacter pylori

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2001.00912.X

Suppressive effects of DNA vaccines encoding heat shock protein on Helicobacter pylori-induced gastritis in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2001.00912.X

A Mr 34,000 proinflammatory outer membrane protein (oipA) of Helicobacter pylori

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2001.00912.X

The neutrophil-activating protein (HP-NAP) of Helicobacter pylori is a protective antigen and a major virulence factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2001.00912.X

Identification of immunodominant antigens from Helicobacter pylori and evaluation of their reactivities with sera from patients with different gastroduodenal pathologies

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2001.00912.X

Immune response to an 18-kilodalton outer membrane antigen identifies lipoprotein 20 as a Helicobacter pylori vaccine candidate

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2001.00912.X

The complete genome sequence of the gastric pathogen Helicobacter pylori

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2001.00912.X

Immunity against Helicobacter pylori: significance of interleukin-4 receptor alpha chain status and gender of infected mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2001.00912.X

Concurrent enteric helminth infection modulates inflammation and gastric immune responses and reduces helicobacter-induced gastric atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2001.00912.X

Cure of Helicobacter pylori infection and resolution of gastritis by adoptive transfer of splenocytes in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2001.00912.X

Immunization with recombinant Helicobacter pylori urease decreases colonization levels following experimental infection of rhesus monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2001.00912.X

Protection of germ-free mice from infection by Helicobacter felis after active oral or passive IgA immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2001.00912.X

Immunisation against gastric infection with Helicobacter species: first step in the prophylaxis of gastric cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2001.00912.X

Comparison between targeted and untargeted systemic immunizations with adjuvanted urease to cure Helicobacter pylori infection in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2001.00912.X

Poliovirus replicons encoding the B subunit of Helicobacter pylori urease elicit a Th1 associated immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2001.00912.X

Quantitative and bioluminescent assay to measure efficacy of conventional and DNA vaccinations against Helicobacter pylori

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2001.00912.X

Therapeutic oral vaccination induces mucosal immune response sufficient to eliminate long-term Helicobacter pylori infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2001.00912.X

Therapeutic immunization against Helicobacter pylori infection in the absence of antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2001.00912.X

Immunization of BALB/c mice against Helicobacter felis infection with Helicobacter pylori urease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2001.00912.X

Local and systemic antibody responses in humans with Helicobacter pylori infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2001.00912.X

Qualitative and quantitative analysis of the local and systemic antibody response in mice and humans with Helicobacter immunity and infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2001.00912.X

Antibody-independent protective mucosal immunity to gastric helicobacter infection in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2001.00912.X

Helicobacter pylori-induced mucosal inflammation is Th1 mediated and exacerbated in IL-4, but not IFN-gamma, gene-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2001.00912.X

Vaccination of gnotobiotic piglets against Helicobacter pylori

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2001.00912.X

10.1046/J.1365-3083.2001.00912.X

21 January 2018

Identifiers

DOI

1 reference

31 July 2017

1 reference